The role of local and systemic cytokines in patients infected with clostridium difficile

Journal of Physiology and Pharmacology

Volumn 65, Issue 5, 2014, Pages 695-703

  Czepiel, Jacek ^a   Biesiada, Grazyna ^a   Brzozowski, T ^a   Ptak Belowska, A ^a   Perucki, W ^a   Birczynska, M ^a   Jurczyszyn, A ^b   Strzalka, M ^a   Targosz, A ^a   Garlicki, A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

Clostridium difficile; Interleukin 10; Interleukin 1 ; Interleukin 6; Interleukin 8; Myeloperoxidase; Prostaglandin E2; Tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MYELOPEROXIDASE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; PEROXIDASE;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROSPECTIVE STUDY; QUANTITATIVE ASSAY; VERY ELDERLY; BLOOD; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PROGNOSIS; PSEUDOMEMBRANOUS COLITIS; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CYTOKINES; DINOPROSTONE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; PROGNOSIS; YOUNG ADULT;

EID: 84908399534     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Hall IC, O'Toole E. Intestinal flora in newborn infants with description of a new pathogenic anaerobe. Am J Dis Child 1935; 49: 390-402.
2. Stanley JD, Bartlett JG, Dart BW, Ashcraft JH. Clostridium difficile infection. Curr Probl Surg 2013; 50: 302-337.
3. Knight CL, Surawicz CM. Clostridium difficile infection. Med Clin North Am 2013; 97: 523-536.
4. Penichea AG, Savidge TC, Dann SM. Recent insights into Clostridium difficile pathogenesis. Curr Opin Infect Dis 2013; 26: 447-453.
5. Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, Viswanatha VK. Clostridium difficile infection toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes 2012; 3: 121-134.
6. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365: 1693-1703.
7. Savidge TC, Pan WH, Newman P, O'Brien M, Anton PM, Pothoulakis C. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology 2003; 125: 413-420.
8. Chumbler NM, Farrow MA, Lapierre LA, et al. Clostridium difficile toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. PLoS Pathog 2012; 8: e1003072.
9. Li S, Shi L, Yang Z, Feng H. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol. Pathog Dis 2013; 67: 11-18.
10. Reinert DJ, Jank T, Aktories K, Schulz GE. Structural basis for the function of Clostridium difficile toxin B. J Mol Biol 2005; 351: 973-981.
11. Madan R, Petri WA Jr. Immune responses to Clostridium difficile infection. Trends Mol Med 2012; 18: 658-666.
12. Sun X, Savidge T, Feng H. The enterotoxicity of Clostridium difficile toxins. Toxins (Basel) 2010; 2: 1848-1880.
13. Fujitani S, George WL, Murthy AR. Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol 2011; 32: 220-228.
14. Kelly CP, Becker S, Linevsky JK, et al. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest 1994; 93: 1257-1265.
15. Qiu B, Pothoulakis C, Castagliuolo I, Nikulasson S, LaMont JT. Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats. Am J Physiol 1999; 276: G485-G490.
16. Jarchum I, Liu M, Shi C, Equinda M, Pamer EG. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun 2012; 80: 2989-2996.
17. Rocha MF, Maia ME, Bezerra LR, et al. Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes. Infect Immun 1997; 65: 2740-2746.
18. Steiner TS, Flores CA, Pizarro TT, Guerrant RL. Fecal lactoferrin, interleukin-1 and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immun 1997; 4: 719-722.
19. El Feghaly RE, Stauber JL, Deych E, Gonzales C, Tarr PI, Haslam DB. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis 2013; 56: 1713-1721.
20. Kelly CP, Kyne L. The host immune response to Clostridium difficile. J Med Microbiol 2011; 60: 1070-1079.
21. Walker AS, Eyre DW, Wyllie DH, et al. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis 2013; 56: 1589-1600.
22. Pepin J, Vo TT, Boutros M, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum 2009; 52: 400-405.
23. Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol 2011;62: 591-599.
24. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510.
25. Kothari N, Bogra J, Abbas H, et al. Tumor necrosis factor gene polymorphism results in high TNF level in sepsis and septic shock. Cytokine 2013; 61: 676-681.
26. Ryan A, Lynch M, Smith SM, et al. A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog 2011; 7: e1002076.
27. Yoshino Y, Kitazawa T, Ikeda M, et al. Clostridium difficile flagellin stimulates toll-like receptor 5, and toxin B promotes flagellin-induced chemokine production via TLR5. Life Sci 2013; 92: 211-217.
28. Hasegawa M, Yamazaki T, Kamada N, et al. Nucleotidebinding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J Immunol 2011; 186:4872-4880.
29. Kim H, Rhee SH, Kokkotou E, et al. Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. J Biol Chem 2005; 280: 21237-21245.
30. Matuchansky C, Mary JY, Bernier JJ. Further studies on prostaglandin E1-induced jejunal secretion of water and electrolytes in man, with special references to the influence of the ethacrynic acid, furosemide, and aspirin. Gastroenterology 1976; 71: 274-281.
31. Lanza FL, Kochman RL, Geis GS, Rack EM, Deysach LG. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits. Am J Gastroenterol 1991; 86: 1743-1748.
32. Eckmann L, Stenson WF, Savidge TC, et al. Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2 alpha production. J Clin Invest 1997; 100: 296-309.
33. Beubler E, Schuligoi R, Chopra AK, Ribardo DA, Peskar BA. Cholera toxin induces prostaglandin synthesis via posttranscriptional activation of cyclooxygenase-2 in the rat jejunum. J Pharmacol Exp Ther 2001; 297: 940-945.
34. Beubler E, Schuligoi R. Mechanisms of cholera toxininduced diarrhea. Ann NY Acad Sci 2000; 915: 339-346.
35. Triadafilopoulos G, Pothoulakis C, O'Brien MJ, LaMont JT. Differential effects of Clostridium difficile toxins Aand B on rabbit ileum. Gastroenterology 1987; 93: 273-279.
36. Warny M, Keates AC, Keates S, et al. P38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest 2000; 105: 1147-1156.
37. Yu Y, Chadee K. Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. J Immunol 1998; 161: 3746-3752.
38. Scher JU, Pillinger MH. The anti-inflammatory effects of prostaglandins. J Investig Med 2009; 57: 703-708.
39. Legler DF, Bruckner M, Uetz-von Allmen E, Krause P. Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol 2010; 42: 198-201.
40. Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D. The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid. J Physiol Pharmacol 2013; 64: 409-421.
41. Aronoff DM, Canetti C, Peters-Golden M. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an Eprostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol 2004; 173: 559-565.
42. Pillinger MH, Philips MR, Feoktistov A, Weissmann G. Crosstalk in signal transduction via EP receptors: prostaglandin E1 inhibits chemoattractant-induced mitogenactivated protein kinase activity in human neutrophils. Adv Prostaglandin Thromboxane Leukot Res 1995; 23: 311-316.
43. Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 2005; 115: 118-128.
44. Largo R, Diez-Ortego I, Sanchez-Pernaute O, et al. EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1b in synovial fibroblasts. Ann Rheum Dis 2004; 63: 1197-1204.
45. Pillinger MH, Marjanovic N, Kim SY, et al. Matrix metalloproteinase secretion by gastric epithelial cells is regulated by E prostaglandins and MAPKs. J Biol Chem 2005; 280: 9973-9979.
46. Tchetina EV, Di Battista JA, Zukor DJ, Antoniou J, Poole AR. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy. Arthritis Res Ther 2007; 9: R75.
47. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2005; 77: 598-625.
48. Hirche TO, Gaut JP, Heinecke JW, Belaaouaj A. Mieloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense. J Immunol 2005; 174: 1557-1565.
49. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999; 67: 1828-1836.
50. Kutter D, Devaquet P, Vanderstocken G. Consequences of total and subtotal myeloperoxidase deficiency: risk of benefit? Acta Haematol 2000; 104: 10-15.
51. Hing TC, Ho S, Shih DQ, et al. The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice. Gut 2013; 62: 1295-1305.
52. Kaur S, Vaishnavi C, Prasad KK, Ray P, Kochhar R. Effect of Lactobacillus acidophilus and epidermal growth factor on experimentally induced Clostridium difficile infection. Indian J Med Res 2011; 133: 434-441.
53. Kaur S, Vaishnavi C, Ray P, Kochhar R, Prasad KK. Effect of biotherapeutics on cyclosporin-induced Clostridium difficile infection in mice. J Gastroenterol Hepatol 2010; 25: 832-838.
54. Hayashi S, Kurata N, Kitahirachi E, et al. Cinacalcet, a calcimimetic, prevents nonsteroidal anti-inflammatory druginduced small intestinal damage in rats. J Physiol Pharmacol 2013; 64: 453-463.
55. Johnson S, Gerding DN, Janoff EN. Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile. J Infect Dis 1992; 166: 1287-1294.
56. Ng J, Hirota SA, Gross O, et al. Clostridium difficile toxininduced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology 2010; 139: 542-552.
57. Savidge TC, Urvil P, Oezguen N, et al. Host S-nitrosylation inhibits Clostridial small molecule-activated glucosylating toxins. Nat Med 2011; 17: 1136-1141.
58. Qiu B, Pothoulakis C, Castagliuolo I, Nikulasson Z, LaMont JT. Nitric oxide inhibits rat intestinal secretion by Clostridium difficile toxin A but not Vibrio cholerae enterotoxin. Gastroenterology 1996; 111: 409-418.
59. Duda-Chodak A. The inhibitory effect of polyphenols on human gut microbiota. J Physiol Pharmacol 2012; 63: 497-503.